Back To: Home

January 19-23, 2015
PepTalk - San Diego, CA

February 7-11, 2015
SLAS2015 - Washington, DC

More Events

New collaboration to validate diabetic nephropathy biomarkers
March 2012

BILLERICA, Mass.—EMD Millipore, the life-science division of Merck KGaA, and Proteomics International recently announced a collaboration for the validation of biomarkers for diabetic nephropathy. Proteomics International's 13 newly identified putative protein biomarkers, which include proteins involved in inflammation, metabolism and oxidative stress, will be assessed using EMD Millipore's multiplex immunoassays. Several of the biomarkers could enhance the current screening method—a microalbumin test consisting of a single biomarker in urine—by identifying a signature of biomarkers in the blood that could better signify disease prediction and progression.  
"We are very excited to be working with EMD Millipore to progress our initial discovery of these biomarkers that could improve diagnosis and health outcomes on such a large scale," said Dr. Richard Lipscombe, managing director of Proteomics International.


Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.